In our efforts to identify drugs that might inhibit BRCA1-deficient tumor growth and metastasis, we found that paclitaxel or docetaxel treatment can reverse the expression pattern of ATP11B and PTDSS2 in breast cancers and significantly inhibit cancer metastasis. Here, PTDSS2 is linked to breast cancer.